MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress Meeting Abstract
| Authors: | Tabernero, J.; Strickler, J.; Nakamura, Y.; Shitara, K.; Janjigian, Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H.; Yoshino, T.; Siena, S.; Garrido-Mayor, J.; Ubowski, M.; Xie, D.; Marshall, J. |
| Abstract Title: | MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress |
| Meeting Title: | ESMO 24th World Congress on Gastrointestinal Cancer 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2022 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | S305 |
| End Page: | S306 |
| Language: | English |
| ACCESSION: | WOS:000823826500169 |
| DOI: | 10.1016/j.annonc.2022.04.246 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P-156 -- Source: Wos |
